Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 13
Submit an article Journal homepage
164
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Transcriptional deregulation of LSD1 and LSD2 is associated with cytogenetic risk in chronic lymphocytic leukemia

Daniel Freitas da Costaa Laboratório de Hematologia e Células-Tronco, Universidade de Brasília, Brasilia, Brasil;b Laboratório de Farmacologia Molecular, Universidade de Brasília, Brasilia, BrasilView further author information
,
Luma Dayane de Carvalho Filiú-Bragaa Laboratório de Hematologia e Células-Tronco, Universidade de Brasília, Brasilia, BrasilView further author information
,
Amandda Évelin Silva-Carvalhoa Laboratório de Hematologia e Células-Tronco, Universidade de Brasília, Brasilia, BrasilView further author information
,
Josiane Lilian Schiavinatoc Laboratório de Hematologia, Universidade de São Paulo, São Paulo, BrazilView further author information
,
Maria Catarina Cals de Vasconcelosd Hospital de Base do Distrito Federal, Setor Hospitalar Sul, Brasília, BrazilView further author information
,
Lorena Lôbo de Figueiredo-Pontesc Laboratório de Hematologia, Universidade de São Paulo, São Paulo, BrazilView further author information
,
Antonio Roberto Lucena-Araujoe Laboratório de Hematologia, Universidade Federal de Pernambuco, Recife, BrazilView further author information
&
Felipe Saldanha-Araujoa Laboratório de Hematologia e Células-Tronco, Universidade de Brasília, Brasilia, Brasil;b Laboratório de Farmacologia Molecular, Universidade de Brasília, Brasilia, BrasilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4200-0821View further author information
ORCID Icon show all
Pages 3227-3231 | Received 08 Jun 2022, Accepted 13 Aug 2022, Published online: 25 Aug 2022

References

  • Baliakas P, Espinet B, Mellink C, et al. Cytogenetics in chronic lymphocytic leukemia: ERIC perspectives and recommendations. Hemasphere. 2022;6(4):e707.
  • Thompson PA, O'Brien SM, Wierda WG, et al. Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens. Cancer. 2015;121(20):3612–3621.
  • Gu F, Lin Y, Wang Z, et al. Biological roles of LSD1 beyond its demethylase activity. Cell Mol Life Sci. 2020;77(17):3341–3350.
  • Fang Y, Liao G, Yu B. LSD1/KDM1A inhibitors in clinical trials: advances and prospects. J Hematol Oncol. 2019;12(1):129.
  • Bagger FO, Sasivarevic D, Sohi SH, et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 2016;44(D1):D917–D924.
  • Put N, Konings P, Rack K, on Behalf of the Belgian Cytogenetic Group for Hemato-Oncology (BCGHO), et al. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: a belgian multicentric study. Genes Chromosom. Cancer. 2009;48(10):843–853.
  • Rigolin GM, Cavallari M, Quaglia FM, et al. In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI. Blood. 2017;129(26):3495–3498.
  • Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404.
  • Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
  • Patel PO, Pishas KI, Taslim C, et al. Investigating the role of LSD2 as an epigenetic regulator in ewing sarcoma. Oncotarget. 2019;10(39):3865–3878.
  • Wada T, Koyama D, Kikuchi J, et al. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation. Blood. 2015;125(24):3731–3746.
  • Wei X, Calvo-Vidal MN, Chen S, et al. Germline Lysine-Specific demethylase 1 (LSD1/KDM1A) mutations confer susceptibility to multiple myeloma. Cancer Res. 2018;78(10):2747–2759.
  • Huang J, Sengupta R, Espejo AB, et al. p53 is regulated by the lysine demethylase LSD1. Nature. 2007;449(7158):105–108.
  • Mosammaparast N, Kim H, Laurent B, et al. The histone demethylase LSD1/KDM1A promotes the DNA damage response. J Cell Biol. 2013;203(3):457–470.
  • Han Y, Hu X, Yun X, et al. Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. Cell Death Dis. 2021;12(11):1083.
  • Trachana V, van Wely KHM, Guerrero AA, et al. Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability. Proc Natl Acad Sci USA. 2007;104(8):2691–2696.
  • Oliveira-Santos W, Rabello DA, Lucena-Araujo AR, et al. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia. Tumour Biol. 2016;37(7):9473–9481.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.